cartcellimmunotherapy2000x1333

FAQ's

Answer : The global eClinical solutions market size was valued at USD 5.9 Billion in 2019 and expected to reach USD 16.36 Billion by 2027.

Answer : The global eClinical solutions market is poised to grow at a compound annual growth rate (CAGR) 13.6% during the forecast period 2020 to 2027.

Answer : Increase in the number of customers adopting eClinical solutions, rising Research and Development (R&D), and rise in government grants to authorize the clinical trials. These solutions are also used in clinical studies where electronic applications enabled with web tools are used to capture the real-time data from clinical trials that provide superior execution and escalate the eClinical solutions market growth.

Answer : In 2019, North America held significant value share in the global eClinical solutions market owing to increase in the number of clinical trials in the region. Further, rising government grants for clinical trials, huge funding in R&D activities, technological advancements, along with significant rise in the lifestyle associated diseases are the key factors that propel the industry growth.

Answer : The Asia Pacific encountered an escalating CAGR over the forecast timespan due to the rising investment in R&D.

Answer : Some of the key players operating in the market are PAREXEL International, Oracle Corp., Bioclinica, Medidata Solution, DATATRAK, ERT Clinical, CRF Health, eClinicalWorks, OmniComm Systems, IBM Watson Health, and eClinical Solutions among others.

Answer : Electronic Clinical Outcome Assessment (eCOA) estimated to be the fastest growing product segment over the analysis period due to rising importance of high-quality clinical data.

Answer : Cloud-based solutions predicted to exhibit strong growth during the analysis period due to integrated features such as high accessibility, flexibility, and easy data backup.